CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement
- 8-K Event Results of operations
- 8-K Event Other events
- 4 Planned sale Chief Scientific Officer sold 372 shares at $1.28 ($476)
- 4 Planned sale Chief Commercial Officer sold 244 shares at $1.26 ($308)
- 4 Planned sale Chief Financial Officer sold 372 shares at $1.26 ($470)
- 4 Planned sale See Remarks sold 361 shares at $1.26 ($456)
- 4 Planned sale See Remarks sold 155 shares at $1.29 ($199)
- 4 Planned sale CEO and President sold 2,134 shares at $1.28 ($2,739)
Page 11 of 34 · 672 filings